Ocimum Biosolutions

Ocimum Biosolutions is a global integrated genomic services company with operations in Hyderabad, India and Houston, TX. We provide comprehensive Bioinformatic services, Reference databases, Genomic services and LIMS solutions.We have been chosen as a global preferred outsourcing provider for more than 75% of top 25 phama and biotech companies plus leading research institutes. With over 12 years of Bioinformatic and genomic expertise, Ocimum is positioned as a solution provider for a data burdened Pharma and Biotech world. Our expertise is from pre-clinical target development and toxicogenomic assessment to clinical biomarker identification and patient stratification. Our expertise is unparalleled and was gained through the creation of the world's largest commercial gene expression databases – BioExpress and ToxExpress. Ocimum has been consistently ranked as one of the fastest growing biotechnology companies and one of the fastest growing technology companies in India and the best bioinformatic company for two years. Ocimum Biosolutions was also listed in the third annual Inc. 5000, an exclusive ranking of America’s fastest-growing private companies.
Company Growth (employees)
Hyderabad, IN
Size (employees)
118 (est)-1%
Ocimum Biosolutions was founded in 2000 and is headquartered in Hyderabad, IN

Key People/Management at Ocimum Biosolutions

Subash Lingareddy

Subash Lingareddy

Founder, President & CFO

Ocimum Biosolutions Office Locations

Ocimum Biosolutions has offices in Hyderabad and Indianapolis
Indianapolis, US
303 3905 Vincennes Rd

Ocimum Biosolutions Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$8 m

Latest funding size

$8 m

Time since last funding

almost 7 years


Ocimum Biosolutions's latest funding round in January 2011 was reported to be $8 m. In total, Ocimum Biosolutions has raised $8 m

Ocimum Biosolutions's Web-traffic and Trends

Ocimum Biosolutions Online and Social Media Presence

Ocimum Biosolutions Company Life and Culture

You may also be interested in